Sally Rafie, PharmD, BCPS, NCMP

It’s important that patients understand how their pharmacy can continue to meet their contraceptive needs during the coronavirus disease 2019 (COVID-19) pandemic.

The second annual States Forum on Pharmacist Birth Control Services recently was held by the Birth Control Pharmacist project in partnership with the National Alliance of State Pharmacy Associations (NASPA).

One highlight of the American Society for Emergency Contraception (ASEC) EC Jamboree was the key clinical discussions centered on drug interactions between emergency contraception and other hormonal contraceptives, including ulipristal acetate.

State representatives shared successes, challenges, and lessons learned.